These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35914785)

  • 41. Vasculitis and calcinosis in juvenile dermatomyositis.
    Truckenbrodt H; Häfner R
    Acta Univ Carol Med (Praha); 1991; 37(1-2):8-15. PubMed ID: 1845413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series.
    Toplak N; Pimpale Chavan P; Rosina S; Dallos T; Rotem Semo O; Aguiar CL; Khubchandani R; Ravelli A; Patwardhan A
    Front Pediatr; 2021; 9():810785. PubMed ID: 35280444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Favorable outcomes with reduced steroid use in juvenile dermatomyositis.
    Orandi AB; Fotis L; Lai J; Morris H; White AJ; French AR; Baszis KW
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):127. PubMed ID: 34404425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary outcome in juvenile dermatomyositis: a case-control study.
    Sanner H; Aaløkken TM; Gran JT; Sjaastad I; Johansen B; Flatø B
    Ann Rheum Dis; 2011 Jan; 70(1):86-91. PubMed ID: 20805295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for developing calcinosis in juvenile dermatomyositis: subcutaneous and myofascial edema in initial magnetic resonance imaging.
    Yi BY; Marrs J; Acharya P; Sura A; Cidon M
    Rheumatol Int; 2023 Jul; ():. PubMed ID: 37432516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis.
    Chung MP; Richardson C; Kirakossian D; Orandi AB; Saketkoo LA; Rider LG; Schiffenbauer A; von Mühlen CA; Chung L; ;
    Autoimmun Rev; 2020 Jun; 19(6):102533. PubMed ID: 32234404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid changes of nailfold capillary abnormalities during treatment for a patient with dermatomyositis complicated by lung cancer: a case report.
    Sugimoto T; Mokuda S; Yamaguchi K; Araki K; Kohno H; Yoshida Y; Hirata S; Hattori N; Sugiyama E
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):95-100. PubMed ID: 32985952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA).
    Orandi AB; Baszis KW; Dharnidharka VR; Huber AM; Hoeltzel MF;
    Pediatr Rheumatol Online J; 2017 Sep; 15(1):71. PubMed ID: 28934971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Calcinosis of childhood dermatomyositis. Apropos of 10 cases].
    Bruguier A; Texier P; Sluzewski W; Ponsot G; Arthuis M
    Helv Paediatr Acta; 1984 Mar; 39(1):47-54. PubMed ID: 6724996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperimmunoglobulin E syndrome with juvenile dermatomyositis and calcinosis.
    Saikia B; Aneja H; Jain J; Puliyel JM
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S51-3. PubMed ID: 20373123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Juvenile amyopathic dermatomyositis and calcinosis].
    Escorial Briso-Montiano M; Solís Sánchez P; Baeza Velasco M; Alonso Rubio A; de Gregorio Alvarez Z
    An Pediatr (Barc); 2005 Mar; 62(3):286-8. PubMed ID: 15737292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review of 23 years of a single center's experience.
    Patwardhan A; Rennebohm R; Dvorchik I; Spencer CH
    Pediatr Rheumatol Online J; 2012 Sep; 10(1):34. PubMed ID: 22995763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options.
    Fredi M; Bartoli F; Cavazzana I; Ceribelli A; Carabellese N; Tincani A; Satoh M; Franceschini F
    Clin Exp Rheumatol; 2017; 35(2):303-308. PubMed ID: 27908312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcinosis in juvenile dermatomyositis: a possible role for the vitamin K-dependent protein matrix Gla protein.
    van Summeren MJ; Spliet WG; van Royen-Kerkhof A; Vermeer C; Lilien M; Kuis W; Schurgers LJ
    Rheumatology (Oxford); 2008 Mar; 47(3):267-71. PubMed ID: 18234711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.
    Al-Mayouf SM; AlMutiari N; Muzaffer M; Shehata R; Al-Wahadneh A; Abdwani R; Al-Abrawi S; Abu-Shukair M; El-Habahbeh Z; Alsonbul A
    Rheumatol Int; 2017 Sep; 37(9):1513-1517. PubMed ID: 28685324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.
    Bingham A; Mamyrova G; Rother KI; Oral E; Cochran E; Premkumar A; Kleiner D; James-Newton L; Targoff IN; Pandey JP; Carrick DM; Sebring N; O'Hanlon TP; Ruiz-Hidalgo M; Turner M; Gordon LB; Laborda J; Bauer SR; Blackshear PJ; Imundo L; Miller FW; Rider LG;
    Medicine (Baltimore); 2008 Mar; 87(2):70-86. PubMed ID: 18344805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM).
    Brown VE; Pilkington CA; Feldman BM; Davidson JE;
    Rheumatology (Oxford); 2006 Aug; 45(8):990-3. PubMed ID: 16467366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.
    Christen-Zaech S; Seshadri R; Sundberg J; Paller AS; Pachman LM
    Arthritis Rheum; 2008 Feb; 58(2):571-6. PubMed ID: 18240225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.
    Sanner H; Gran JT; Sjaastad I; Flatø B
    Rheumatology (Oxford); 2009 Dec; 48(12):1541-7. PubMed ID: 19776224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ureteral calcinosis in juvenile dermatomyositis: successful precocious surgical management.
    Duarte RJ; Denes FT; Sallum AM
    Int Braz J Urol; 2006; 32(5):574-7. PubMed ID: 17081329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.